Senti Biosciences Inc [SNTI] stock prices are up 7.41% to $1.16 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The SNTI shares have gain 5.45% over the last week, with a monthly amount drifted -3.33%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Senti Biosciences Inc [NASDAQ: SNTI] stock has seen the most recent analyst activity on October 14, 2025, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $12. Previously, Laidlaw started tracking the stock with Buy rating on June 06, 2025, and set its price target to $5. On October 07, 2022, Morgan Stanley initiated with a Equal-Weight rating and assigned a price target of $7.50 on the stock.
The stock price of Senti Biosciences Inc [SNTI] has been fluctuating between $1.02 and $5.10 over the past year. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Senti Biosciences Inc [NASDAQ: SNTI] shares were valued at $1.16 at the most recent close of the market. An investor can expect a potential return of 417.24% based on the average SNTI price forecast.
Analyzing the SNTI fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.9, Equity is -1.98 and Total Capital is -1.63. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 3.71.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Senti Biosciences Inc [NASDAQ:SNTI]’s Current Ratio is 1.51. On the other hand, the Quick Ratio is 1.51, and the Cash Ratio is 1.02.
Transactions by insiders
Recent insider trading involved Lu Timothy K, CEO, that happened on Feb 04 ’25 when 3922.0 shares were sold. CEO, Lu Timothy K completed a deal on Feb 06 ’25 to sell 545.0 shares. Meanwhile, Pres. & Chief Med. & Dev. Off. Rajangam Kanya sold 1297.0 shares on Feb 04 ’25.
